The Carotenoids Industry sales study offers a comprehensive analysis on diverse features including production capacities, Carotenoids demand, product developments, sales revenue generation and Carotenoids market outlook across the globe.
market research report by Fact.MR, (Leading business and competitive intelligence provider) on global Carotenoids market sales initiates with an outlook of the market, followed by the scrutiny of the demand and consumption volumes and share and size of various end-use segments
Sales of carotenoids are likely to surpass US$ 2 Bn by 2031 attributed to the growing emphasis on healthy and natural food along with supplement consumption on account of rising health issues.
The readability score of the Carotenoids market demand report is good as it offers chapter-wise layout with each section divided into a smaller sections.
The report encompasses graphs and tables to show the entire assembling. Pictorial demonstration of the definite and estimated values of key segments is visually appealing to readers.
This Carotenoids market outlook report explicates on vital dynamics such as the drivers, restraints and opportunities for key players and competitive analysis of Carotenoids along with key stakeholders as well as emerging players associated with the manufacturing of product.
The Key trends Analysis of Extended Carotenoids market also provides dynamics that are responsible for influencing the future sales and demand of over the forecast period.
Key Companies Profiled
- BASF S.E.
- Koninklijke DSM N.V.
- Givaudan Group
- Dr. Reddy’s Laboratories
- Cipla
- Sun Pharmaceutical
- GSK,
- Roche
- Novo Nordisk
Questionnaire answered in the market outlook report of Carotenoids include:
- What is the key strategy deployed by large players to maximize Carotenoids market growth?
- What are the main challenges faced by players in the Carotenoids market demand?
- With the advent of technological advancement, how will the Carotenoids market landscape change over the forecast period?
- What does player bring to the table, which is unique as a strategy, and is easy to emulate for new investors in the Carotenoids market size?
How will be insights and market estimations provided in the Fact.MR report on the demand of Carotenoids make a difference?
- The study takes a closer look at the major economic turmoil, with a focus on the recent COVID-19 pandemic disruptions
- The assessment of key growth dynamics highlights the attractiveness of new automation technologies and offers readers insight on the prospect of these during the forecast period
- The study tries to offer a balance perspective of the opportunities in mature and the most lackluster markets
- Provides scrutiny of the industry trends that have shaped recent government policies
- Provides an account of major breakthroughs in all segments that might change the course of the market considerably
- Provides an incisive analysis of socio-political milieu in which the key markets operate, and how will that influence the lucrativeness of the overall Carotenoids market
- Analyzes how collaborations and partnerships among players from different industries shape the key growth dynamics in the near future
- Evaluates the role of various stages of funding on new growth avenues in key regional markets
Competitive Landscape
In a rapidly changing business and competitive landscape, organizations need to keep up with the ongoing market trends to stay ahead of their industry rivals. To achieve this, global manufacturers of carotenoids are taking bold steps to expand their business reach. They are focusing on adopting innovative marketing strategies, technological developments, and mergers and acquisitions.
- In Aug 2018 BASF Animal Nutrition launched its Lucantin® NXT product line in the EU 28 market. The next generation of carotenoids is stabilized by propyl gallate (PG) and butylhydroxytoluene (BHT) or tocopherol.
- In Oct 2020 Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces the completion of its acquisition of Erber Group for an enterprise value of €980 million.
- The acquisition of Erber Group’s Biomin further strengthens DSM’s expertise and reputation as a leading provider of animal health and nutrition solutions for farm productivity and sustainability, with an emphasis on emissions reduction, feed consumption efficiency, and better use of water and land.
Key Segments Covered:
- Product
- Beta-Carotene Carotenoids
- Lutein Carotenoids
- Astaxanthin Carotenoids
- Canthaxanthin Carotenoids
- Lycopene Carotenoids
- Other Carotenoids
- Source
- Natural Carotenoids
- Synthetic Carotenoids
- End Use
- Carotenoids for Food & Beverage Colorants
- Carotenoids for Animal Feed Additives
- Carotenoids for Dietary Supplements & Nutraceutical Ingredients
- Carotenoids for Pharmaceutical Additives
- Carotenoids for Cosmetic & Personal Care Additives
Written By